Lexeo Therapeutics Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Lexeo Therapeutics Inc in the second quarter 2026?
Lexeo Therapeutics Inc recorded a cumulative net loss of $-87 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -41.85%.

Within the Biotechnology & Pharmaceuticals industry 43 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 2641 to 3205.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Equity Change	70.07 %	162.72 %	111.11 %	-13.27 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-87	-88	-100	-105	-114
Return On Equity (TTM)	-41.85 %	-47.48 %	-67.33 %	-90.49 %	-94.65 %
LXEO's Total Ranking	# 3205	# 2641	# 2988	# 1142	# 2806
Equity (TTM) in Millions	235	231	247	121	138
Seq. Equity Change	1.54 %	-6.15 %	104.14 %	-12.58 %	56.86 %
Seq. Net Income Change	-	-	-	-	-

Back to LXEO Management Effectiveness >> LXEO's 5 Years Annual ROE >> Compare LXEO ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 44
Sector	# 373
Overall	# 3205

Return On Equity Statistics
High	Average	Low
-41.85 %	-199.38 %	-1339.92 %
(Jun 30 2026)		(Mar 31 2024)

LXEO Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023
Total Equity in Millions	247	117	114	0	0
Y / Y Equity Change	111.11 %	2.91 %	-	-	-
Net Income in Millions	-100	-98	-66	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-40.52 %	-84.16 %	-58.48 %	-	-

Back to LXEO Management Effectiveness >> LXEO's 5 Years Annual ROE >> Compare LXEO ROE to its Competitors

More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LXEO's' Return on Equity at Yahoo Finance
LXEO's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LXEO's Competitors
Subscribers only: Roe for Lexeo Therapeutics Inc 's Suppliers
Subscribers only: Return On Equity for LXEO's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector

ROE

Date modified: 2026-09-26T07:42:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.